1 1

Medical Education Hub

UCLA 17th Annual UCLA Liver Diseases Symposium 2024

UCLA 17th Annual UCLA Liver Diseases Symposium 2024

€10,00 EUR
€10,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.

UCLA 17th Annual UCLA Liver Diseases Symposium 2024

Include: 8 videos + 9 pdfs, size: 2.69 GB
Target Audience: physicians, hepatologists, radiologists, and surgeons
 Information:


Date & Location: Saturday, October 26, 2024, 7:15 AM – 2:00 PM, Hyatt Regency Westlake, Westlake, CA

Overview

The 17th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.
Target Audience
Specialties – Family Medicine, Internal Medicine, Radiology, Surgery
Professions – Advanced Practice Nurse, Fellow/Resident, Nurse, Other, Physician, Physician Assistant
Objectives
At the conclusion of this activity, learners will be able to:
  1. Diagnose and manage patients with advanced liver disease and be better able to prognosticate and risk stratify those patients for medical procedures.
  2. Understand the current process of evaluation, listing and organ allocation in liver transplantation.
  3. Identify the risks and benefits of interventional radiology (IR) procedures for the management and treatment of clinically significant portal hypertension in patients with advanced liver disease.
  4. Use evidence-based recommendations in the evaluation and management of hepatocellular carcinoma (HCC).
  5. Discuss the role of current and recently approved second line therapies in the treatment of primary biliary cholangitis (PBC).
  6. Evaluate and properly stratify patients with metabolic dysfunctionassociated steatotic liver disease (ie, fatty liver), and develop tailored therapies to prevent disease progression.
  7. Review treatment options for patients with alcohol hepatitis and optimal long-term care.
  8. Identify the most common causes of drug induced liver injury (DILI) and learn to assess which cases are likely to resolve or progress.
  9. Diagnose acute liver failure, risk stratify patients, and identify those likely to recover and those likely to require a liver transplant.

 

 Topics:
  • 230443_BROCHURE.pdf
  • Changes in Evaluation, Listing, and Organ Allocation in Liver Transplantation.mp4
  • Current Evaluation and Treatment of Metabolic Dysfunction Associated Liver Disease.pdf
  • Evaluating-Induced Liver Injury – When to be Concerned.mp4
  • Evaluating-Induced Liver Injury – When to be Concerned.pdf
  • Multidisciplinary Approach for Patients with Alcohol Liver Disease Including Those with Alcohol Hepatitis – Perspectives from Hepatology and Addiction Medicine.mp4
  • Multidisciplinary Approach for Patients with Alcohol Liver Disease Including Those with Alcohol Hepatitis – Perspectives from Hepatology and Addiction Medicine.pdf
  • New Concepts in Portal Hypertension and Risk Stratification of Patients with Liver Cirrhosis.mp4
  • New Concepts in Portal Hypertension and Risk Stratification of Patients with Liver Cirrhosis.pdf
  • New Therapies in Primary Biliary Cholangitis and Approaches in Autoimmune Hepatitis.mp4
  • New Therapies in Primary Biliary Cholangitis and Approaches in Autoimmune Hepatitis.pdf
  • Panel Case Discussion Multi-Disciplinary Approach to Liver Cancer.mp4
  • Panel Case Discussion Multi-Disciplinary Approach to Liver Cancer.pdf
  • Panel Discussion- Acute on Chronic and Fulminant Liver Failure.mp4
  • Panel Discussion- Acute on Chronic and Fulminant Liver Failure.pdf
  • Radiologic Treatment of Refractory Hepatic Encephalopathy, Ascites, and Variceal Bleeding.mp4
  • Radiologic Treatment of Refractory Hepatic Encephalopathy, Ascites, and Variceal Bleeding.pdf
View full details